Zymeworks Enters its First ZymeLink Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics Read more
Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus Read more
Michel Mikhail invites Biosimilar experts to attend SMi’s 10th Annual Biosimilars Conference Read more
ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies Read more
Celgene Announces POMALYST Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma Read more